Role of inflammatory indices in management of hepatocellular carcinoma-neutrophil to lymphocyte ratio
- PMID: 32953712
- PMCID: PMC7475436
- DOI: 10.21037/atm-2020-90
Role of inflammatory indices in management of hepatocellular carcinoma-neutrophil to lymphocyte ratio
Conflict of interest statement
Conflicts of Interest: The author has completed the ICMJE uniform disclosure from (available at http://dx.doi.org/10.21037/atm-2020-90). The author has no conflicts of interest to declare.
Comment on
-
The neutrophil-to-lymphocyte ratio is a predictive factor for the survival of patients with hepatocellular carcinoma undergoing transarterial chemoembolization.Ann Transl Med. 2020 Apr;8(8):541. doi: 10.21037/atm.2020.02.113. Ann Transl Med. 2020. PMID: 32411764 Free PMC article.
Similar articles
-
Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma.ESMO Open. 2021 Feb;6(1):100020. doi: 10.1016/j.esmoop.2020.100020. Epub 2021 Jan 4. ESMO Open. 2021. PMID: 33399083 Free PMC article.
-
Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization.Br J Biomed Sci. 2018 Oct;75(4):187-191. doi: 10.1080/09674845.2018.1494769. Epub 2018 Aug 21. Br J Biomed Sci. 2018. PMID: 29991324
-
Neutrophil-lymphocyte ratio predicts the therapeutic benefit of neoadjuvant transarterial chemoembolization in patients with resectable hepatocellular carcinoma.Eur J Gastroenterol Hepatol. 2020 Sep;32(9):1186-1191. doi: 10.1097/MEG.0000000000001629. Eur J Gastroenterol Hepatol. 2020. PMID: 31851089
-
Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.World J Gastroenterol. 2015 May 14;21(18):5598-606. doi: 10.3748/wjg.v21.i18.5598. World J Gastroenterol. 2015. PMID: 25987785 Free PMC article.
-
Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma.J Hepatocell Carcinoma. 2018 Jan 18;5:17-28. doi: 10.2147/JHC.S86792. eCollection 2018. J Hepatocell Carcinoma. 2018. PMID: 29404284 Free PMC article. Review.
Cited by
-
The role of platelet-lymphocyte ratio in hepatocellular carcinoma: a valuable prognostic marker.Transl Cancer Res. 2022 Dec;11(12):4231-4234. doi: 10.21037/tcr-22-2343. Transl Cancer Res. 2022. PMID: 36644176 Free PMC article. No abstract available.
-
Role of peripheral inflammatory biomarkers, transforming growth factor-beta and interleukin 6 in predicting peritoneal adhesions following repeat cesarean delivery.Ir J Med Sci. 2022 Dec;191(6):2697-2704. doi: 10.1007/s11845-021-02878-8. Epub 2022 Jan 6. Ir J Med Sci. 2022. PMID: 34988860
-
The Prognostic Values of Neutrophil-to-lymphocyte Ratio and Platelet-to-Lymphocyte Ratio at Baseline in Predicting the In-hospital Mortality in Black African Patients with Advanced Hepatocellular Carcinoma in Palliative Treatment: A Comparative Cohort Study.Hepat Med. 2021 Dec 8;13:123-134. doi: 10.2147/HMER.S333980. eCollection 2021. Hepat Med. 2021. PMID: 34938131 Free PMC article.
-
Systemic Immune-Inflammation Index (SII) Can Be an Early Indicator for Predicting the Severity of Acute Pancreatitis: A Retrospective Study.Int J Gen Med. 2021 Dec 8;14:9483-9489. doi: 10.2147/IJGM.S343110. eCollection 2021. Int J Gen Med. 2021. PMID: 34949937 Free PMC article.
-
Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapy.World J Gastrointest Oncol. 2024 Oct 15;16(10):4037-4041. doi: 10.4251/wjgo.v16.i10.4037. World J Gastrointest Oncol. 2024. PMID: 39473946 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources